NASDAQ: NEUP
Neuphoria Therapeutics Inc Earnings Dates, Reports, Calls

Neuphoria Therapeutics earnings were N/A for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest NEUP earnings report on Mar 31, 2025 announced Q1 2025 earnings of $7.1M, down 690.5% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, NEUP reported annual earnings of -$10.3M, with -30% growth.

NEUP earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

NEUP Return on Equity

Insufficient data to display

NEUP undefined

Insufficient data to display

Be the first to know when NEUP announces earnings.

NEUP undefined

Current Company
0%
Current Industry
5.8%

NEUP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NEUPN/AN/AN/AN/A
BRTX-$11.78M-$12.10MN/A-$1.47
NERV$6.27M$6.25M-11.88%$0.82
ABP-$8.18M-$20.25MN/A-$0.69
ICU-$15.79M-$15.91MN/A-$3.10

Neuphoria Therapeutics Earnings Reports & History FAQ

What were Neuphoria Therapeutics's earnings last quarter?

Neuphoria Therapeutics (NASDAQ: NEUP) reported Q1 2025 earnings per share (EPS) of $4.15, up 322.66% year over year. Total NEUP earnings for the quarter were $7.13 million. In the same quarter last year, Neuphoria Therapeutics's earnings per share (EPS) was -$1.86.

If you're new to stock investing, here's how to buy Neuphoria Therapeutics stock.

Is Neuphoria Therapeutics profitable or losing money?

As of the last Neuphoria Therapeutics earnings report, Neuphoria Therapeutics is currently losing money. Neuphoria Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was N/A, a N/A decrease year over year.

What was NEUP's earnings growth in the past year?

As of Neuphoria Therapeutics's earnings date in Q2 2025, Neuphoria Therapeutics's earnings has grown year over year. NEUP earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.